| Mrs Kelli Branstad, LMFT | |
|
3640 9th St Nw, Rochester, MN 55901-6685 | |
| (507) 424-3234 | |
| Not Available |
| Full Name | Mrs Kelli Branstad |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 3640 9th St Nw, Rochester, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417331216 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 2856 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kelli Branstad, LMFT 3640 9th St Nw, Rochester, MN 55901-6685 Ph: (507) 424-3234 | Mrs Kelli Branstad, LMFT 3640 9th St Nw, Rochester, MN 55901-6685 Ph: (507) 424-3234 |
News Archive
Some supporters of abortion rights fear that any current changes could be used sometime in the future to restrict the option for women. Meanwhile, an appeal court rules that some morning-after pills should be available over the counter immediately.
In just a few years, CAR T-cell and other adoptive T-cell therapies have emerged as among the most promising forms of cancer immunotherapy.
Santarus, Inc., a specialty biopharmaceutical company, today announced that analysis of top-line safety data from a double blind, multicenter 12-month extended use study in patients treated daily with either the investigational drug budesonide MMX 6 mg or placebo will be provided as support for the company's planned submission of a New Drug Application (NDA) for budesonide MMX 9 mg to the U.S. Food and Drug Administration (FDA) for the induction of remission of mild or moderate active ulcerative colitis.
Cancer researchers from Rice University have deciphered the operating principles of a genetic switch that cancer cells use to decide when to metastasize and invade other parts of the body. The study found that the on-off switch's dynamics also allows a third choice that lies somewhere between "on" and "off." The extra setting both explains previously confusing experimental results and opens the door to new avenues of cancer treatment.
Anadys Pharmaceuticals, Inc. today announced preliminary results from a planned interim analysis of data at four weeks for the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
› Verified 6 days ago
Yvette A Kidman, MA, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 300 3rd Ave Se Ste 402, Rochester, MN 55904 Phone: 507-218-8973 Fax: 507-206-0450 | |
Dwight D Dobell, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 124 Elton Hills Ln Nw, Rochester, MN 55901 Phone: 507-282-1009 | |
Valerie J Presa, MS Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 300 3rd Ave Se, Rochester, MN 55904 Phone: 507-322-6755 | |
Ralph Patton, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1700 Broadway Ave N, Suite 101, Rochester, MN 55906 Phone: 507-884-6287 | |
Mary Susan Schuelke, MA, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 124 Elton Hills Ln Nw, Rochester, MN 55901 Phone: 507-282-1009 Fax: 507-282-0932 | |
Dewina Lavern Anderson Kraus, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 5255 Members Pkwy Nw, Rochester, MN 55901 Phone: 507-218-3701 | |
Jonathan R Kruse, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 15 15th Ave Ne, Rochester, MN 55906 Phone: 507-993-2893 Fax: 507-282-0932 |